Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database.
Publication/Presentation Date
7-1-2026
Volume
18
Issue
13
ISSN
2072-6694
Published In/Presented At
Chiang, L., Bodzin, A., Lin, D., Hanna, N., Koeneman, S., Dang, H., Yeo, C. J., Shubert, C., & Zheng, R. (2026). Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database. Cancers, 18(13), 2137. https://doi.org/10.3390/cancers18132137
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
42449679
Department(s)
Administration and Leadership
Document Type
Article
COinS